Correlation Between Zymeworks Common and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zymeworks Common and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zymeworks Common and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zymeworks Common Stock and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Zymeworks Common and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zymeworks Common with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zymeworks Common and Day One.

Diversification Opportunities for Zymeworks Common and Day One

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Zymeworks and Day is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Zymeworks Common Stock and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Zymeworks Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zymeworks Common Stock are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Zymeworks Common i.e., Zymeworks Common and Day One go up and down completely randomly.

Pair Corralation between Zymeworks Common and Day One

Given the investment horizon of 90 days Zymeworks Common Stock is expected to generate 1.21 times more return on investment than Day One. However, Zymeworks Common is 1.21 times more volatile than Day One Biopharmaceuticals. It trades about -0.05 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  1,476  in Zymeworks Common Stock on September 3, 2024 and sell it today you would lose (67.00) from holding Zymeworks Common Stock or give up 4.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Zymeworks Common Stock  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Zymeworks Common Stock 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Zymeworks Common Stock are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Zymeworks Common exhibited solid returns over the last few months and may actually be approaching a breakup point.
Day One Biopharmaceu 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Day One Biopharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Zymeworks Common and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zymeworks Common and Day One

The main advantage of trading using opposite Zymeworks Common and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zymeworks Common position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Zymeworks Common Stock and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets